PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID)
Vol. 3 No. 3 (2024): JULY

GENE EXPRESSIONS IN THE INCIDENCE OF NON-SYNDROMIC CLEFT LIP AND PALATE

Al Hafiz, Al Hafiz (Unknown)
Supriyadi, Fauzia Latifah (Unknown)
Raymond, Benni (Unknown)



Article Info

Publish Date
12 Nov 2024

Abstract

The cleft lip and aisle (CL/P) are a craniofacial malformation caused by genetic mutations, environmental factors, or an interaction between the two. The development of the lip and auricle involves morphogenesis, molecular signaling pathways, mesenchymal-epithelial interactions, and auricle fusion. CL/P events involve initiation, growth, morphogenesis, and auctioning fusion. The Genome-Wide Association Study (GWAS) identified genes and loci associated with non-syndromic CL/P into 43 types significantly associated with single nucleotide polymorphism (SNP) near the gene. This systematic review aims to explore the genetic underpinnings of CL/P by analyzing findings from Genome-Wide Association Studies (GWAS) and identifying key genes and molecular pathways involved in palatogenesis. The most significant genes and loci in non-syndromic CL/P were Interferon regulatory factor 6 (IRF6), MAF bZIP transcription factor B (MAFB), Paired Box 7 (PAX7), Forkhead Box E1 (FOXE1), Msh Homeobox 1 (MSX1), T-box transcription factor 22 (TBX22), and Methylenetetrahydrofolate reductase (MTHFR). Genetic factors play an essential role in the pathogenesis of non-syndromic CL/P, including disruption of signaling pathways. IRF6, MAFB, PAX7, FOXE1, MSX1, TBX22, and MTHFR are genes that play a role in palatogenesis. Mutations in these genes have an impact on orofacial development.

Copyrights © 2024






Journal Info

Abbrev

COMORBID

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Medicine & Pharmacology Neuroscience Nursing

Description

About the Journal PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID) is an international, modern, general medical publication that publishes research on all aspects of medicine, from fundamental research to significant clinical trials and cost-effectiveness analyses. We ...